top of page
RECENT POST

FDA Q1/Q2 Sameness Received for Fourth Product

  • Writer: Troy Chavis
    Troy Chavis
  • Dec 1, 2018
  • 1 min read

ChoroPharma, LLC has received FDA's response confirming Q1/Q2 sameness for our fourth ophthalmic suspension medication. Quality by design and registration batches are planned to begin Q1 2019.


 
 
 

Comments


ChoroPharma, LLC
Research Triangle Park, NC 27607

Phone: 803-807-3936

bottom of page